Merck KGaA Extends Takeover Deadline for AZ Electronics

German chemicals and pharmaceuticals producer Merck KGaA has extended the takeover offer for AZ Electronics after acceptance of its £1.6 billion (about €200 million) cash bid fell short of the target by the first closing date.

Merck said on Jan. 22 that its offer had been accepted by only 39.8% of the Luxembourg-based electronics firm's existing share capital. It subsequently extended the deadline until February 5. The German company had initially said the offer would close in mid-February.

Under British law, Merck could lower the acceptance level, the news agency Reuters pointed out. However, the bid already represents a 40% premium over the average share price over the past three months.

When announcing the takeover plans in December, Merck CEO Karl-Ludwig Kley said the deal would allow the Darmstadt company to lift its profile in the high-margin electronics space beyond the display industry, where it already is a leading supplier of liquid crystals for displays.

AZ Electronics, of once part of defunct chemical conglomerate Hoechst, manufactures materials used in integrated circuits, flat panel displays and light-emitting diodes.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read